PeptideScanner
Peptide Scanner does not sell peptides. Independent, not affiliated with any supplier. Disclaimer

Everlife

Telehealth or clinicBased in DERanked #1Checked November 5, 2026
3 of 3
of our own checks pass
—
consult fee not published
5
covered peptides on sale

Information only. Not medical advice. A US-licensed prescriber decides. We do not sell, prescribe or take payment from these pharmacies.

Compare Everlife with other providers

Can you get a prescription peptide from Everlife?

Ranked: sells a covered peptide now and passes 3 of our 3 checks.

40 / 100

Ranked #1

Higher than 99% of the 613 sellers we score

-5 points: markets peptides outside the six covered.

Held at 40 (raw 48): markets peptides outside the six.

Everlife 40
Typical seller 12Best 400100

The shaded part is the sellers Everlife scores higher than.

Legal basics35 / 44License, gated checkout, wording, FDA letters, routes
  • Dispensing pharmacy license: Pass, 12 of 12. Texas State Board of Pharmacy: CUREXA, licence 34357, Active, expires 07/31/2028, 3007 Ocean Heights Ave, Egg Harbor Township NJ, no prior disciplinary orders. Same name and address as the site's 'Partner Pharmacy' notice on the BPC-157 page. Texas non-resident record; the New Jersey home board was not checked. The site says prescriptions go to 'one of Everlife's partner pharmacies' and names only Curexa. pharmacy.texas.gov ↗ (November 5, 2026)
  • Medical step before payment: Pass, 8 of 8. On the BPC-157 page, 'Start BPC-157' opens a question flow at /bpc-157/h2/basic-user-info, labelled '3 MINUTE MEDICAL QUIZ FOR YOUR RX'. Its first question asks about physical activity and no payment field is shown. Stopped there, nothing selected. Page says 'Requires a quick online consultation' and 'A licensed provider will review your information'. FAQ says 'You're charged when your clinician approves your treatment and the pharmacy begins filling it'. The later steps were not seen. everlifemd.com ↗ (November 5, 2026)
  • No research-use wording: Pass, 4 of 4. No research-use wording on the pages selling the peptide, the home page or FAQ/terms pages. everlifemd.com ↗ (November 5, 2026)
  • No FDA warning letter: Pass, 7 of 7. FDA warning letter index search (Everlife; everlifemd.com) found no letter to this company (5 Nov 2026) fda.gov ↗ (November 5, 2026)
  • No legal action found: Unknown, 0 of 4. No match in ps-peptide-suits/our legal-actions dataset (name + domain) and 0 results in a justice.gov news search for the exact name (5 Nov 2026). Court dockets and state board actions not searched, so not marked pass. justice.gov ↗ (November 5, 2026)
  • Single peptide only, no blends: Pass, 4 of 4. Treatment list and peptide page show BPC-157, TB-500, MOTS-C, KPV and Epitalon as single products. The 'Featured Stacks' heading covers single items here, and the only combination products named (Sermorelin GHK, Optima NAD+) hold no covered peptide. everlifemd.com ↗ (November 5, 2026)
  • Only the 6 covered peptides: Fail, 0 of 2. Same pages sell PT-141 and Sermorelin GHK (sublingual Sermorelin with GHK-Cu and L-Citrulline), which are outside the six. Sermorelin alone and topical GHK-Cu cream are not counted, per earlier runs. everlifemd.com ↗ (November 5, 2026)
  • Routes allowed by the policy: Fail, 0 of 3. route(s) outside Appendix B: kpv: injection everlifemd.com ↗ (November 5, 2026)
  • Licenses in other states: Unknown, no points. not checked (November 5, 2026)
Quality evidence0 / 35Lot testing, API maker, accreditation, sterility
  • Ingredient maker named: Unknown, 0 of 8. not checked (November 5, 2026)
  • Ingredient maker FDA-registered: Unknown, 0 of 9. not checked (November 5, 2026)
  • Batch test reports: Unknown, 0 of 8. not checked (November 5, 2026)
  • PCAB or ACHC accreditation: Unknown, 0 of 5. not checked (November 5, 2026)
  • Endotoxin and sterility testing: Unknown, 0 of 5. not checked (November 5, 2026)
Transparency13 / 21Public prices, states served, LegitScript, reviews
  • Prices public: Pass, 5 of 5. public price for: bpc-157, tb-500, epitalon, mots-c, kpv everlifemd.com ↗ (November 5, 2026)
  • States listed: Pass, 3 of 3. ['AL', 'AK', 'AZ', 'AR', 'CA', 'CO', 'CT', 'DE', 'DC', 'FL', 'GA', 'HI', 'ID', 'IL', 'IN', 'IA', 'KS', 'KY', 'LA', 'ME', 'MD', 'MA', 'MI', 'MN', 'MS', 'MO', 'MT', 'NE', 'NV', 'NH', 'NJ', 'NM', 'NY', 'NC', 'ND', 'OH', 'OK', 'OR', 'PA', 'RI', 'SC', 'SD', 'TN', 'TX', 'UT', 'VT', 'VA', 'WA', 'WV', 'WI', 'WY'] everlifemd.com ↗ (November 5, 2026)
  • LegitScript certified: Unknown, 0 of 5. not checked (November 5, 2026)
  • Customer reviews: Pass, 5 of 5. Trustpilot: Everlife, TrustScore 4.9, 2,732 reviews (5 Nov 2026) trustpilot.com ↗ (November 5, 2026)
  • Policy label shown: Unknown, 0 of 3. not checked (November 5, 2026)
Tap a row to see every check. How the score works

Our 3 checks

We checked these ourselves rather than trust the site.

  1. 1
    Pass

    Dispensing pharmacy license

    What their site says
    “Partner Pharmacy Pharmacy: Curexa 3007 Ocean Heights Ave Egg Harbor Township, NJ 08234”
    What we found

    Texas State Board of Pharmacy: CUREXA, licence 34357, Active, expires 07/31/2028, 3007 Ocean Heights Ave, Egg Harbor Township NJ, no prior disciplinary orders. Same name and address as the site's 'Partner Pharmacy' notice on the BPC-157 page. Texas non-resident record; the New Jersey home board was not checked. The site says prescriptions go to 'one of Everlife's partner pharmacies' and names only Curexa.

    Checked November 5, 2026 · pharmacy.texas.gov ↗
  2. 2
    Pass

    Medical step before payment

    On the BPC-157 page, 'Start BPC-157' opens a question flow at /bpc-157/h2/basic-user-info, labelled '3 MINUTE MEDICAL QUIZ FOR YOUR RX'. Its first question asks about physical activity and no payment field is shown. Stopped there, nothing selected. Page says 'Requires a quick online consultation' and 'A licensed provider will review your information'. FAQ says 'You're charged when your clinician approves your treatment and the pharmacy begins filling it'. The later steps were not seen.

    Checked November 5, 2026 · everlifemd.com ↗ · Stopped at everlifemd.com
  3. 3
    Pass

    No research-use wording

    No research-use wording on the pages selling the peptide, the home page or FAQ/terms pages.

    Checked November 5, 2026 · everlifemd.com ↗

Wrong? Unknown means we could not confirm it from public sources, not a finding against Everlife. Send evidence and we will re-check

Who fills the order and who prescribes

We read the main pages of the Everlife site (home, peptide, about, FAQ and policy pages, not every page) and public records on November 5, 2026.

Dispensing pharmacy Named

The site's Partner Pharmacy notice names Curexa, 3007 Ocean Heights Ave, Egg Harbor Township NJ. Texas board licence 34357 is Active at that address.

“Partner Pharmacy Pharmacy: Curexa 3007 Ocean Heights Ave Egg Harbor Township, NJ 08234” everlifemd.com ↗
  • Curexa, Egg Harbor Township, NJ.Texas State Board of Pharmacy (non-resident license): license #34357, Active, expires July 31, 2028.Board record ↗

Checked November 5, 2026

Prescribers named on the site

No prescriber named.

No prescriber named on the pages read.

Covered peptides offered

Checked November 5, 2026

BPC-157injection$180per month, 2.5 mg/mL 6 mL vialSubcutaneous, Intramuscular, Oral, TopicalSource
TB-500injection$180per month, 2.5 mg 6 mL vialSubcutaneous, IntramuscularSource
Epitaloninjection$209per month, 2 mg/mL 5 mL vialSubcutaneous, IntramuscularSource
MOTS-cinjection$180per month, 10 mg/mL 5 mL vialSubcutaneous, IntramuscularSource
KPVinjection$180per month, 2 mg 5 mL vialTopical, OralSource

Legal name: Everlife LLC · Website: everlifemd.com ↗ · Prescription: Required, per the seller's site. Source ↗ · Pharmacy that fills it: Curexa · States served: AL, AK, AZ, AR, CA, CO, CT, DE, DC, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, WY

We don't sell peptides or prescribe. No pharmacy pays for its score. How we score · All prescription sellers · Report an issue with this page